Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: a Critical Review on the Background and Clinical Utility.

Sinn, P; Aulmann, S; Wirtz, R; Schott, S; Marmé, F; Varga, Z; Lebeau, A; Kreipe, H; Schneeweiss, A

Sinn, P; Aulmann, S; Wirtz, R; Schott, S; Marmé, F; Varga, Z; Lebeau, A; Kreipe, H; Schneeweiss, A.

Afiliación

Sinn P; Department of Pathology, University of Heidelberg, Heidelberg.
Aulmann S; Department of Pathology, University of Heidelberg, Heidelberg.
Wirtz R; Stratifyer Molecular Pathology GmbH, Köln.
Schott S; Department of Gynaecology and Obstetrics, University of Heidelberg, Heidelberg.
Marmé F; Department of Gynaecology and Obstetrics, University of Heidelberg, Heidelberg.
Varga Z; Institute of Surgical Pathology, University Hospital Zürich, Zürich, Switzerland.
Lebeau A; Dept. of Pathology, University Medical Canter Hamburg-Eppendorf, Hamburg.
Kreipe H; Institute of Pathology, Medizinische Hochschule Hannover, Hannover.
Schneeweiss A; National Center of Tumor Diseases, Heidelberg.

Geburtshilfe Frauenheilkd ; 73(9): 932-940, 2013 Sep.

Article en En | MEDLINE | ID: mdl-24771945

Palabras clave

breast cancer; multigene assays; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Geburtshilfe Frauenheilkd Año: 2013 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google